Issue 12, 2022
From the journal:

RSC Advances

Correction: Surface modification of intraocular lenses with hyaluronic acid and lysozyme for the prevention of endophthalmitis and posterior capsule opacification

Bailiang Wang,ab   Quankui Lin,*ab   Tingwei Jin,c   Chenghui Shen,b   Junmei Tang,a   Yuemei Hana  and  Hao Chen*ab  

* Corresponding authors

a School of Ophthalmology & Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, China
E-mail: lqk97531@126.com, Chenhao823@mail.eye.ac.cn
Fax: +86 577 88067962

b Wenzhou Institute of Biomaterials and Engineering, Chinese Academy of Sciences, Wenzhou, China

c Department of Basic Teaching, City College of Wenzhou University, Wenzhou, China

Abstract

Correction for ‘Surface modification of intraocular lenses with hyaluronic acid and lysozyme for the prevention of endophthalmitis and posterior capsule opacification’ by Bailiang Wang et al., RSC Adv., 2015, 5, 3597–3604, DOI: 10.1039/c4ra13499k.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/D2RA90020C
Article type
Correction
Submitted
25 Feb 2022
Accepted
25 Feb 2022
First published
07 Mar 2022
This article is Open Access
Creative Commons BY license

RSC Adv., 2022,12, 7403-7404

Permissions

Request permissions

Correction: Surface modification of intraocular lenses with hyaluronic acid and lysozyme for the prevention of endophthalmitis and posterior capsule opacification

B. Wang, Q. Lin, T. Jin, C. Shen, J. Tang, Y. Han and H. Chen, RSC Adv., 2022, 12, 7403 DOI: 10.1039/D2RA90020C

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements